AXOSIM, INC.

Medtech · Private

3D rodent brain spheroid microphysiological system for CNS neurotoxicity screening

axosim.com →
Grants
$4.1M
8 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
15
3 granted · 12 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing$224,859
Federal grantNational Science Foundation · Phase I · STTR Phase I: Human Microphysiological Model for Assaying the Efficacy of Drugs for Myelin Disorders$225,000
Federal grantDepartment of Health and Human Services · Phase II · Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing$2,083,328
Federal grantDepartment of Health and Human Services · Phase II · Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing$39,927
Federal grantDepartment of Health and Human Services · Phase II · Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing$839,860
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Development of 3D Rat Nerve-on-a-Chip Model for Chemical Toxicity Screening$197,625
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase II · Peripheral Nerve-on-a-chip for Predictive Preclinical Pharmaceutical Testing$240,000
Federal grantDepartment of Health and Human Services · Phase I · Myelinated Rodent Brain Spheroids for High-throughput Evaluation of Neurotoxicity$227,946
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1787LA JOLLA ALCOHOL RESEARCH INC——
1788Cambre Kelly——
1789STARLIGHT CARDIOVASCULAR INC——
1790AXOSIM, INC.——
1791BATANDCAT, INC.——
1792DANDELION SCIENCE CORP——
1793NEURALTRAK, INC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 3 granted of 15

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.